1. Executive Summary
2. Research Methodology
3. Coronary Artery Stents
3.1 Background
3.2 Overview
3.3 Classification
3.3.1 Bare Metal Stent (BMS)
3.3.2 Drug-eluting stents (DES)
3.3.3 Bioresorbable stents (BRS)
4. Market Analysis
4.1 Market Sizing (Actual & Foreacsted)
4.2 Market Share Analysis
4.2.1 Market Share by Types
4.2.2 Market Share by Region
4.3 Pricing Trend
5. Bioresorbable Stents
5.1 Overview
5.2 Market Sizing (Actual & Forecasted)
5.3 Market Share Analysis
5.3.1 Market Share by Type of Material
5.3.2 Market Share by Application
5.3.3 Market Share by Absorption Rate
5.3.4 Market Share by Region
6. Regional Analysis
6.1 North America
6.1.1 Coronary Stent Market Sizing (Actual & Forecasted)
6.1.2 Market Share by Stent Type
6.1.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
6.1.4 The US
6.1.4.1 Stent Market Sizing (Actual & Forecasted)
6.1.4.2 Market Share by Products
6.1.4.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
6.2 Europe
6.2.1 Coronary Stent Market Sizing (Actual & Forecasted)
6.2.2 Market Share by Stent Type
6.2.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Coronary Stent Market Sizing (Actual & Forecasted)
6.3.2 Market Share by Stent Type
6.3.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Use of Premium Alloys for Stenting
7.1.3 Advent of X-Ray Visible Absorbable Embolic Bead
7.1.4 FDA Approval of First Dedicated Coronary Bifurcation Stent
7.2 Growth Drivers
7.2.1 Increasing Geriatric Population
7.2.2 Prevalence of Coronary & Peripheral Artery Diseases
7.2.3 Favorable Reimbursement Policies
7.3 Challenges
7.3.1 Stringent Regulations
7.3.2 Post-Operative Complications
7.3.3 Slow Adoption Rate
7.3.4 High Cost of Devices
8. Competitive Landscape
8.1 Coronary Stents
8.1.1 Market Share Analysis
8.2 Bioresorbable Stents
8.2.1 Market Share Analysis
8.2.2 Brand Analysis
9. Company Profiles
9.1 Abbott Laboratories
9.2 Medtronic PLC
9.3 Boston Scientific Corporation
9.4 REVA Medical
9.5 Biotronik Inc.